Ontology highlight
ABSTRACT:
SUBMITTER: Su Y
PROVIDER: S-EPMC5999919 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
Su Yudong Y Meng Zhaoting Z Xu Xiaoyan X Wang XinYue X Zuo Ran R Hou Yunxia Y Li Kai K Chen Peng P
Zhongguo fei ai za zhi = Chinese journal of lung cancer 20180501 5
In recent years, the number of advanced non-small cell lung cancer (NSCLC) patients has gradually increased, and the treatment methods have also been significantly increased. However, there are no standard treatment plans at home and abroad for third-line and above patients who are refractory to targeted therapy epidermal growth factor receptor (EGFR)/anaplastic lymphoma kinase (ALK) or chemotherapy. The clinical treatment effect is also not satisfactory. Anlotinib is a novel TKI targeting the v ...[more]